Home » Pharma News » Department of Biotechnology is about to begin a research on Monogenic Disorders

Department of Biotechnology is about to begin a research on Monogenic Disorders

With an aim to control the onset of various monogenic disorders such as the metabolic disorders, endocrine disorders, hemoglobin disorders and others, the Department of Biotechnology (DBT) will soon begin research on monogenic disorders.

Read more @http://www.pharmabiz.com/NewsDetails.aspx?aid=101466&sid=1

Thanks for the comment

BIGTheme.net • Free Website Templates - Downlaod Full Themes